Skip to main content

and
  1. Article

    Open Access

    Clinical application of thioredoxin reductase as a novel biomarker in liver cancer

    Hepatic cancer is often amenable to surgery, including percutaneous ablation, trans-arterial chemoembolization. However, in metastatic cases, surgery is often not an effective option. Chemotherapy as a convent...

    Xu** Wu, Qi Wang, Yousheng Lu, **ye Zhang, Hanwei Yin in Scientific Reports (2021)

  2. Article

    Open Access

    Publisher Correction: Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    **aodong **e, Huifang Nie, Yu Zhou, Shu Lian, Hao Mei, Yusheng Lu in Nature Communications (2020)

  3. Article

    Open Access

    Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles

    There are disease-causing biohazards in the blood that cannot be treated with modern medicines. Here we show that an intelligently designed safe biomaterial can precisely identify, tow and dump a targeted bioh...

    **aodong **e, Huifang Nie, Yu Zhou, Shu Lian, Hao Mei, Yusheng Lu in Nature Communications (2019)

  4. Article

    Open Access

    Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells

    Carcinoma metastasis is triggered by a subpopulation of circulating tumor cells (CTCs). And single immune checkpoint therapy is not good enough to inhibit CTC-induced metastasis. Here, we demonstrate that simu...

    Shu Lian, Ruizhi **e, Yuying Ye, Yusheng Lu, Yunlong Cheng in Scientific Reports (2019)

  5. Article

    Open Access

    Sex-related pharmacokinetic differences and mechanisms of metapristone (RU486 metabolite)

    Metapristone is the primary metabolite of the abortifacient mifepristone (RU486), and is being developed as a safe and effective cancer metastatic chemopreventive agent for both sexes. Here, we systematically ...

    Wenge Chen, Yingying **ao, Jianzhong Chen, Jian Liu, **gwei Shao in Scientific Reports (2017)

  6. Article

    Open Access

    Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention

    Metapristone is the most predominant biological active metabolite of mifepristone and being developed as a novel cancer metastasis chemopreventive agent by us. Despite its prominent metastasis chemopreventive ...

    Suhong Yu, Cuicui Yan, **ngtian Yang, Sudang He, Jian Liu in Scientific Reports (2016)

  7. Article

    Open Access

    Multivalent Conjugation of Antibody to Dendrimers for the Enhanced Capture and Regulation on Colon Cancer Cells

    Circulation tumor cells (CTCs) in the bloodstream of early-stage cancer patients carry the important information about valuable biomarkers and biological properties of primary tumor. However, detection and cap...

    **g**g **e, Jichuang Wang, Hongning Chen, Weiyu Shen in Scientific Reports (2015)

  8. Article

    Open Access

    Systems pharmacology of mifepristone (RU486) reveals its 47 hub targets and network: Comprehensive analysis and pharmacological focus on FAK-Src-Paxillin complex

    Mifepristone (RU486), a synthetic steroid compound used as an abortifacient drug, has received considerable attention to its anticancer activity recently. To explore the possibility of using mifepristone as a ...

    Suhong Yu, **ngtian Yang, Yewei Zhu, Fangwei **e, Yusheng Lu, Ting Yu in Scientific Reports (2015)

  9. Article

    Open Access

    Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis

    Ursolic acid (UA) is a naturally bioactive product that exhibits potential anticancer effects. The relatively safe and effective molecule intrigued us to explore a way to further improve its anti-cancer activi...

    Jichuang Wang, Zhou Jiang, Yuanfang Li, Minrui Ou in Scientific Reports (2014)

  10. Article

    Open Access

    Nitric Oxide Inhibits Hetero-adhesion of Cancer Cells to Endothelial Cells: Restraining Circulating Tumor Cells from Initiating Metastatic Cascade

    Adhesion of circulating tumor cells (CTCs) to vascular endothelial bed becomes a crucial starting point in metastatic cascade. We hypothesized that nitric oxide (NO) may prevent cancer metastasis from happenin...

    Yusheng Lu, Ting Yu, Haiyan Liang, Jichuang Wang, **g**g **e in Scientific Reports (2014)